Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Immunity ; 56(6): 1187-1203.e12, 2023 06 13.
Article in English | MEDLINE | ID: mdl-37160118

ABSTRACT

B7 ligands (CD80 and CD86), expressed by professional antigen-presenting cells (APCs), activate the main co-stimulatory receptor CD28 on T cells in trans. However, in peripheral tissues, APCs expressing B7 ligands are relatively scarce. This raises the questions of whether and how CD28 co-stimulation occurs in peripheral tissues. Here, we report that CD8+ T cells displayed B7 ligands that interacted with CD28 in cis at membrane invaginations of the immunological synapse as a result of membrane remodeling driven by phosphoinositide-3-kinase (PI3K) and sorting-nexin-9 (SNX9). cis-B7:CD28 interactions triggered CD28 signaling through protein kinase C theta (PKCθ) and promoted CD8+ T cell survival, migration, and cytokine production. In mouse tumor models, loss of T cell-intrinsic cis-B7:CD28 interactions decreased intratumoral T cells and accelerated tumor growth. Thus, B7 ligands on CD8+ T cells can evoke cell-autonomous CD28 co-stimulation in cis in peripheral tissues, suggesting cis-signaling as a general mechanism for boosting T cell functionality.


Subject(s)
CD28 Antigens , CD8-Positive T-Lymphocytes , Mice , Animals , CD28 Antigens/metabolism , Antigens, CD/metabolism , Ligands , Synaptic Membranes/metabolism , B7-2 Antigen , Membrane Glycoproteins/metabolism , B7-1 Antigen/metabolism , Cell Adhesion Molecules , Lymphocyte Activation
SELECTION OF CITATIONS
SEARCH DETAIL
...